Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Osiris Therapeutics, Inc.    OSIR   US68827R1086

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/25/2014 07/28/2014 07/29/2014 07/30/2014 07/31/2014 Date
14.72(c) 14.5(c) 14.94(c) 14.58(c) 14.64 Last
132 445 113 028 125 721 162 142 161 982 Volume
+1.38% -1.49% +3.03% -2.41% +0.41% Change
More quotes
Company
Osiris Therapeutics, Inc. is a stem cell company, which focuses on developing and marketing products to treat medical conditions in the inflammatory, cardiovascular, orthopedic and wound healing markets. The company operates its business through two segments: Therapeutics and Biosurgery segment.... 
Surperformance© rating of Osiris Therapeutics, Inc.
Trading Rating : - Investor Rating :
More about the company
Chart OSIRIS THERAPEUTICS, INC.
Duration : Period :
Osiris Therapeutics, Inc. Technical Analysis Chart | OSIR | US68827R1086 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 47,1 M
EBIT 2014 -3,68 M
Net income 2014 2,75 M
Debt 2014 -
Yield 2014 -
Sales 2015 64,7 M
EBIT 2015 0,27 M
Net income 2015 1,15 M
Debt 2015 -
Yield 2015 -
PER 2014 208,29
PER 2015 486,00
Capi. / Sales 2014 10,6x
Capi. / Sales 2015 7,71x
Capitalization 499 M
More Financials
Latest news on OSIRIS THERAPEUTICS, INC.
1d ago OSIRIS THERAPEUTICS' : Grafix Manuscript Available Online
4d ago OSIRIS THERAPEUTICS : Bolsters Its Grafix Product Portfolio
4d ago OSIRIS THERAPEUTICS : Upgrades Its Grafix Product Portfolio and Introduces Addit..
6d ago OSIRIS THERAPEUTICS : ' Grafix Manuscript Released Online
07/23 OSIRIS THERAPEUTICS : Expands its Grafix® Product Portfolio and Launches Additio..
07/22 OSIRIS THERAPEUTICS : Grafix® Manuscript from Osiris' Multi-center, Randomized, ..
07/22 OSIRIS THERAPEUTICS : Grafix® Manuscript from Osiris’ Multi-center, Random..
07/22 OSIRIS THERAPEUTICS : Enhances Its Grafix Product Portfolio
07/21 OSIRIS THERAPEUTICS : Upgrades Its Grafix Product Portfolio and Offers Additiona..
07/16 OSIRIS THERAPEUTICS : Expands its Grafix® Product Portfolio and Launches Additio..
07/14 OSIRIS THERAPEUTICS : Announces Second Quarter 2014 Financial Results Conference..
06/26 OSIRIS THERAPEUTICS : to Participate in Annual JMP Securities Healthcare Confere..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
Osiris Therapeutics, Inc. : Income Statement Evolution
More Financials
EPS Revisions
Osiris Therapeutics, Inc. : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF